Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Interventional Neurology Devices Market: By Product Type, By Technology Type, By Indication, By End User and Region Forecast 2019-2030
Interventional Neurology Devices Market size valued US$ 2.8 billion in 2023 and is poised to grow at a CAGR of 9.2% from 2024-2030. Interventional neurology is a speciality which utilizes the minimally invasive procedures with image-guided techniques for the diagnosis and treatment of various chronic neurological diseases related to veins & arteries of neck, brain, and spine. The most commonly treated diseases with interventional neurology include head and neck tumours, ischemic strokes, meningiomas, spinal vascular malformations, cerebral aneurysm, and intracranial atherosclerosis among others. Different types of materials such as cobalt, platinum, and nitinol are used in neurovascular devices for ischemic stroke prevention and aneurysm.
Increase in the global aging population, technological advancements in the interventional neurology devices, a rise in prevalence of ischemic stroke and hemorrhagic conditions, and growing demand for minimally invasive procedures are anticipated to fuel the market. Furthermore, advantages of an interventional procedure such as the minimal possibility of infection and surgical trauma, favourable reimbursement policies, and rise in product development and commercialization are expected to bolster the market over the forecast period. However, stringent regulatory guidelines for the product approvals, a high cost of the treatment, and lack of skilled professionals might impede the growth of the market.
In June 2017, DePuy Synthes acquired Sentio, LLC to enable the innovation in minimally invasive surgery of spine In October 2016, St. Jude Medical, Inc. received FDA approval for Amplatzer PFO used in the treatment of recurrent ischemic stroke and launched in U.S. market
Study Period
2024-2030Base Year
2023CAGR
9.2%Largest Market
North AmericaFastest Growing Market
North America
The market is growing at a significant CAGR owing to increase in the demand for minimally invasive neurological surgical procedures. A rise in the prevalence of neurological disorders (according to World Health Organization, more than 6.8 Mn people are dying from neurological disorders) expected to drive the revenue growth of market. Moreover, a majority of the market players are focusing on the development of novel devices with minimally invasive techniques. Acquisitions and mergers, collaborations, product approvals, and launchings are strategies followed by the companies for dominating the market. For instance, in June 2016, Terumo Corporation acquired Sequent Medical, Inc. for the development of a novel medical device for the aneurysm embolization. Moreover, in January 2012, Covidien received FDA approval for the Solitaire revascularization device interventional management of stroke trial.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 2.8 billion |
Market CAGR |
9.2% |
By Product Type |
|
By Technology |
|
By Indication |
|
By End User |
|
By Region |
|
Download Free Sample Report
Interventional neurology devices market size valued US$ 2.8 billion in 2023 and is poised to grow at a CAGR of 9.2% from 2024-2030.
The market key players are Medtronic plc) (Ireland), Stryker Corporation (U.S.), Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.), Abbott Laboratories (U.S.), Terumo Corporation (Japan), Bayer AG (Germany), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.)
North America is the fastest-growing region for interventional neurology devices market
1. Executive Summary |
2. Global Interventional Neurology Devices Market Introduction |
2.1.Global Interventional Neurology Devices Market - Taxonomy |
2.2.Global Interventional Neurology Devices Market - Definitions |
2.2.1.Product Type |
2.2.2.Technology |
2.2.3.Indication |
2.2.4.End User |
2.2.5.Region |
3. Global Interventional Neurology Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Interventional Neurology Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Interventional Neurology Devices Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Cerebral Balloon Angioplasty and Stenting Systems, |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Neurothrombectomy Devices, |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Support Devices, |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Aneurysm Coiling and |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Embolization Devices |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Interventional Neurology Devices Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Carotid Artery Angioplasty and Stenting |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Vertebroplasty |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Stroke Therapy |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Pre-operative Tumour Embolization |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Interventional Neurology Devices Market By Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Cerebral Aneurysm, |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Ischemic Strokes, |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Arteriovenous Malformations and Fistulas, |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Interventional Neurology Devices Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Hospitals, |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Neurology Clinics, |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Ambulatory Surgical Centres |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9. Global Interventional Neurology Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. North America Interventional Neurology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Cerebral Balloon Angioplasty and Stenting Systems, |
10.1.2.Neurothrombectomy Devices, |
10.1.3.Support Devices, |
10.1.4.Aneurysm Coiling and |
10.1.5.Embolization Devices |
10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Carotid Artery Angioplasty and Stenting |
10.2.2.Vertebroplasty |
10.2.3.Stroke Therapy |
10.2.4.Pre-operative Tumour Embolization |
10.3. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Cerebral Aneurysm, |
10.3.2.Ischemic Strokes, |
10.3.3.Arteriovenous Malformations and Fistulas, |
10.3.4.Others |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals, |
10.4.2.Neurology Clinics, |
10.4.3.Ambulatory Surgical Centres |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Europe Interventional Neurology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Cerebral Balloon Angioplasty and Stenting Systems, |
11.1.2.Neurothrombectomy Devices, |
11.1.3.Support Devices, |
11.1.4.Aneurysm Coiling and |
11.1.5.Embolization Devices |
11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Carotid Artery Angioplasty and Stenting |
11.2.2.Vertebroplasty |
11.2.3.Stroke Therapy |
11.2.4.Pre-operative Tumour Embolization |
11.3. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Cerebral Aneurysm, |
11.3.2.Ischemic Strokes, |
11.3.3.Arteriovenous Malformations and Fistulas, |
11.3.4.Others |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals, |
11.4.2.Neurology Clinics, |
11.4.3.Ambulatory Surgical Centres |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Asia Pacific (APAC) Interventional Neurology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Cerebral Balloon Angioplasty and Stenting Systems, |
12.1.2.Neurothrombectomy Devices, |
12.1.3.Support Devices, |
12.1.4.Aneurysm Coiling and |
12.1.5.Embolization Devices |
12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Carotid Artery Angioplasty and Stenting |
12.2.2.Vertebroplasty |
12.2.3.Stroke Therapy |
12.2.4.Pre-operative Tumour Embolization |
12.3. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Cerebral Aneurysm, |
12.3.2.Ischemic Strokes, |
12.3.3.Arteriovenous Malformations and Fistulas, |
12.3.4.Others |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals, |
12.4.2.Neurology Clinics, |
12.4.3.Ambulatory Surgical Centres |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13. Middle East and Africa (MEA) Interventional Neurology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Cerebral Balloon Angioplasty and Stenting Systems, |
13.1.2.Neurothrombectomy Devices, |
13.1.3.Support Devices, |
13.1.4.Aneurysm Coiling and |
13.1.5.Embolization Devices |
13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Carotid Artery Angioplasty and Stenting |
13.2.2.Vertebroplasty |
13.2.3.Stroke Therapy |
13.2.4.Pre-operative Tumour Embolization |
13.3. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Cerebral Aneurysm, |
13.3.2.Ischemic Strokes, |
13.3.3.Arteriovenous Malformations and Fistulas, |
13.3.4.Others |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals, |
13.4.2.Neurology Clinics, |
13.4.3.Ambulatory Surgical Centres |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14. Latin America Interventional Neurology Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Cerebral Balloon Angioplasty and Stenting Systems, |
14.1.2.Neurothrombectomy Devices, |
14.1.3.Support Devices, |
14.1.4.Aneurysm Coiling and |
14.1.5.Embolization Devices |
14.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Carotid Artery Angioplasty and Stenting |
14.2.2.Vertebroplasty |
14.2.3.Stroke Therapy |
14.2.4.Pre-operative Tumour Embolization |
14.3. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Cerebral Aneurysm, |
14.3.2.Ischemic Strokes, |
14.3.3.Arteriovenous Malformations and Fistulas, |
14.3.4.Others |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals, |
14.4.2.Neurology Clinics, |
14.4.3.Ambulatory Surgical Centres |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Medtronic plc) (Ireland) |
15.2.2.Stryker Corporation (U.S.) |
15.2.3.Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.) |
15.2.4.Abbott Laboratories (U.S.) |
15.2.5.Terumo Corporation (Japan) |
15.2.6.Bayer AG (Germany) |
15.2.7.Boston Scientific Corporation (U.S.) |
15.2.8.Penumbra, Inc. (U.S.) |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players